Each month, the NATA scientific committee organises a one-hour interactive session led by top experts, featuring a hot topic related to clinical practice.
Registered participants can submit questions during the session.
Moderator:
Prof Jens Meier, Linz, Austria
Anticoagulation Stewardship: what is it, why do we need it, who should do it, how do we do it.
Dr Pieter Wessels, Cape Town, South Africa
Objectives:
Tranexamic Acid for Heavy Menstrual Bleeding and Post-Partum Hemorrhage
Dr Michelle Sholzberg, Toronto, Canada
Objectives:
Speakers
Dr Pieter Wessels, Cape Town, South Africa
Dr Michelle Sholzberg, Toronto, Canada
Dr Michelle Sholzberg is an Adult Hematologist and Clinician Scientist with a focus on coagulation, iron deficiency and health equity.
She is an Associate Professor and the Departmental Division Director of Hematology at the University of Toronto, and the Division Head of Hematology Oncology and Medical Director of the Coagulation Laboratory at St. Michael’s Hospital. She is also the Director of the Hematology-Oncology Clinical Research Group and the Hemequity Lab.
Currently, she is involved in the study of: prediction tools for perioperative and traumatic bleeding, the intersection of women’s health and bleeding disorders, treatments for iron deficiency anemia, and new treatments for immune thrombocytopenia.
Summary: Patient Blood Management (PBM) is not just a clinical tool—it’s a key patient safety strategy. However, recent analysis has shown that although the benefits of PBM have been proven, it is yet not optimally introduced into clinical routine practice.
This session explores how PBM can reduce harm, improve outcomes, and optimize resources. However, it also addresses potential risks when PBM is misapplied and highlights the need for a team-based, patient-centred approach.
Learning Objectives
